International comparison of the development methods and results of the SF-6D value sets
With the increasing application of pharmacoeconomic evaluation evidence in health decision-making,it highlights the need of improving the quality.Health-related quality of life,especially health utility value,plays an important role in cost-utility analysis.Conducting relevant research can significantly contribute to improving the quality of evidence for pharmacoeconomic evaluation.Although the Chinese SF-6D value set has been estimated based on the health preferences of local population,there lack comprehensive comparative studies across different countries or regions.To facilitate the further research and application of the SF-6D and other similar scales in China,and to inform better decision-making,this study systematically compared the estimation method and final recommendation of the SF-6D utility value sets in 12 countries or regions such as China,UK,Australia and others.
short-form six-dimensionsvalue sethealth-related quality of lifepharmacoeconomic
NETL
NSTL
万方数据
